Navigation Links
Wayne State researcher receives NSF award to develop neural implants

DETROIT Neural implants have the potential to treat disorders and diseases that typically require long-term treatment, such as blindness, deafness, epilepsy, spinal cord injury, and Alzheimer's and Parkinson's. However, implantable devices have been problematic in clinical applications because of bodily reactions that limit device functioning time.

Mark Ming-Cheng Cheng, Ph.D., assistant professor of electrical and computer engineering at Wayne State University, is out to change that. He recently received a five-year, $475,000 Faculty Early Career Development (CAREER) grant from the National Science Foundation to study the potential of graphene, a novel carbon material, in the development of a reliable, high-performance, long-term implantable electrode system to improve quality of life using nanotechnology. Cheng is collaborating with colleagues in the School of Medicine, in biomedical engineering, and in WSU's Smart Sensors and Integrated Microsystems and Nano Incubator programs.

Neural disorders and diseases result when parts of the brain don't interact properly or stop interacting altogether. Cheng said that over the past 50 years, electrodes used to stimulate connections between those parts typically stop working after a few weeks because scar tissue forms around the electrode, and the materials that comprise the electrode can't carry enough charge through the scar tissue.

Cheng hypothesizes that graphene, a flexible material recently discovered by Russian scientists, might be better suited to long-term treatment than platinum and iridium oxide, two of the most popular materials now used to make implantable electrodes. Making platinum and iridium oxide electrodes small enough to be implanted reduces the amount of charge they can carry and therefore limits their ability to stimulate neural connections. Additionally, Cheng said, signals from these electrodes to machines that record neural activity often contain a lot "noise" because of the impedance levels of the materials.

Graphene, he said, enables a larger electrical charge and can be made smaller than previous electrodes, yet still big enough to do the job. The smaller size and higher conductivity also decreases impedance, enabling clearer readings of neural activity, Cheng said.

Using graphene electrodes poses a challenge, however, because its flexibility makes it difficult to insert into tissue. In order to overcome that issue, Cheng plans to use a porous silicone "backbone" that slowly and safely biodegrades into brain tissue while releasing anti-inflammatory medication, thus limiting the formation of scar tissue.

Though it's too early to tell how long a graphene electrode will hold up after implantation, Cheng said a five-year lifespan would yield a "huge" number of potential applications in areas like neuroscience, drug delivery, bioelectronics, biosensors and security.

"Real-time sensing and treatment by neural implants can be used to treat a variety of neurological maladies," Cheng said, adding that more than 200,000 patients with full or partial paralysis may benefit from the technology in the United States alone. The cost of care for those patients is well over $200 billion annually, he said.

"This research will help advance fundamental knowledge of the interaction between the neural system and biomaterials of different electrochemical, mechanical and material properties," Cheng said. "Understanding the fundamental mechanism is important in the development of neural prostheses to aid people with disabilities."


Contact: Julie O'Connor
Wayne State University - Office of the Vice President for Research

Related medicine news :

1. Wayne State University engineering student receives American Tinnitus Association award
2. Wayne State University researcher argues that sex reduces genetic variation
3. Health providers should emphasize breast cancer screening, Wayne State University research finds
4. Religion benefits traumatic brain injury victims, Wayne State University research finds
5. Wayne State University researchers win grant from the NSF to target tinnitus
6. Wayne State researchers find new way to examine major depressive disorder in children
7. Wayne State leads study to improve management of cancer pain in African Americans
8. Wayne State study links testosterone with mens ability to woo potential mates
9. Wayne State University researchers publish results settling multiple sclerosis debate
10. Speaking the same language means better health care quality, Wayne State University study finds
11. Wayne State University study predicts risk of memory loss in healthy, older adults
Post Your Comments:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: